SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-03-004273
Filing Date
2003-03-14
Accepted
2003-03-14 13:29:34
Documents
1
Period of Report
2003-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd6311.htm 4 16343
  Complete submission text file 0001181431-03-004273.txt   18584
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Subject) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 4 | Act: 34 | File No.: 000-10824 | Film No.: 03603725
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Reporting) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
SIC: 2835 In Vitro & In Vivo Diagnostic Substances